| Mutations of the BRAF gene in human cancer H Davies, GR Bignell, C Cox, P Stephens, S Edkins, S Clegg, J Teague, ... Nature 417 (6892), 949-954, 2002 | 13210 | 2002 |
| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 11354* | 2021 |
| Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic … SL James, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1789-1858, 2018 | 9989 | 2018 |
| Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global … H Wang, M Naghavi, C Allen, RM Barber, ZA Bhutta, A Carter, DC Casey, ... The lancet 388 (10053), 1459-1544, 2016 | 5736 | 2016 |
| Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990 … HH Kyu, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1859-1922, 2018 | 3829 | 2018 |
| New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk J Dupuis, C Langenberg, I Prokopenko, R Saxena, N Soranzo, ... Nature genetics 42 (2), 105-116, 2010 | 2585 | 2010 |
| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 2545* | 2020 |
| Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic … GBD 2015 Risk Factors Collaborators Lancet (London, England) 388 (10053), 1659, 2016 | 2532 | 2016 |
| Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 NJ Kassebaum, A Bertozzi-Villa, MS Coggeshall, KA Shackelford, ... The Lancet 384 (9947), 980-1004, 2014 | 2057 | 2014 |
| Use of oral corticosteroids and risk of fractures TP Van Staa, HGM Leufkens, L Abenhaim, B Zhang, C Cooper Journal of bone and mineral research 15 (6), 993-1000, 2000 | 2020 | 2000 |
| The Heidelberg classification of renal cell tumours G Kovacs, M Akhtar, BJ Beckwith, P Bugert, CS Cooper, B Delahunt, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 1997 | 1707 | 1997 |
| Common variants near MC4R are associated with fat mass, weight and risk of obesity RJF Loos, CM Lindgren, S Li, E Wheeler, JH Zhao, I Prokopenko, ... Nature genetics 40 (6), 768-775, 2008 | 1600 | 2008 |
| The evolutionary history of lethal metastatic prostate cancer G Gundem, P Van Loo, B Kremeyer, LB Alexandrov, JMC Tubio, ... Nature 520 (7547), 353-357, 2015 | 1512 | 2015 |
| European guidance for the diagnosis and management of osteoporosis in postmenopausal women JA Kanis, N Burlet, C Cooper, PD Delmas, JY Reginster, F Borgstrom, ... Osteoporosis international 19, 399-428, 2008 | 1465 | 2008 |
| The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study TW O'neill, D Felsenberg, J Varlow, C Cooper, JA Kanis, AJ Silman, ... Journal of bone and mineral research 11 (7), 1010-1018, 1996 | 1415 | 1996 |
| Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 NJ Kassebaum, RM Barber, ZA Bhutta, L Dandona, PW Gething, SI Hay, ... The lancet 388 (10053), 1775-1812, 2016 | 1385 | 2016 |
| Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo … RECORD Trial Group The Lancet 365 (9471), 1621-1628, 2005 | 1267 | 2005 |
| Molecular cloning of a new transforming gene from a chemically transformed human cell line CS Cooper, M Park, DG Blair, MA Tainsky, K Huebner, CM Croce, ... Nature 311 (5981), 29-33, 1984 | 1239 | 1984 |
| Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven G Attard, AHM Reid, TA Yap, F Raynaud, M Dowsett, S Settatree, ... Journal of clinical oncology 26 (28), 4563-4571, 2008 | 1090 | 2008 |
| Multiple newly identified loci associated with prostate cancer susceptibility RA Eeles, Z Kote-Jarai, GG Giles, AAA Olama, M Guy, SK Jugurnauth, ... Nature genetics 40 (3), 316-321, 2008 | 1017 | 2008 |
